Does the media prefer IBT or WWH?

In the previous week, Worldwide Healthcare had 3 more articles in the media than International Biotechnology. MarketBeat recorded 4 mentions for Worldwide Healthcare and 1 mentions for International Biotechnology. Worldwide Healthcare's average media sentiment score of 1.60 beat International Biotechnology's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment International Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Worldwide Healthcare 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor IBT or ASL?

In the previous week, International Biotechnology and International Biotechnology both had 1 articles in the media. Aberforth Smaller Companies Trust's average media sentiment score of 1.13 beat International Biotechnology's score of 0.00 indicating that Aberforth Smaller Companies Trust is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment International Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aberforth Smaller Companies Trust 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to JMG or IBT?

In the previous week, JPMorgan Emerging Markets and JPMorgan Emerging Markets both had 1 articles in the media. JPMorgan Emerging Markets' average media sentiment score of 0.75 beat International Biotechnology's score of 0.00 indicating that JPMorgan Emerging Markets is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment JPMorgan Emerging Markets 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive International Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

International Biotechnology (IBT) Competitors

GBX 1,120 -15.00 (-1.32%)

As of 09/1/2026 11:56 AM Eastern

Compare

IBT vs. WWH, BNKR, ASL, BHMG, and JMG

Should you buy International Biotechnology stock or one of its competitors? International Biotechnology's main competitors and comparable companies include Worldwide Healthcare (WWH), The Bankers Investment Trust (BNKR), Aberforth Smaller Companies Trust (ASL), BH Macro GBP (BHMG), and JPMorgan Emerging Markets (JMG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does International Biotechnology compare to Worldwide Healthcare?

International Biotechnology (LON:IBT) and Worldwide Healthcare (LON:WWH) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

In the previous week, Worldwide Healthcare had 3 more articles in the media than International Biotechnology. MarketBeat recorded 4 mentions for Worldwide Healthcare and 1 mentions for International Biotechnology. Worldwide Healthcare's average media sentiment score of 1.60 beat International Biotechnology's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Biotechnology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Worldwide Healthcare	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.8%. Worldwide Healthcare pays an annual dividend of GBX 2.40 per share and has a dividend yield of 0.6%. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Worldwide Healthcare pays out 9.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Worldwide Healthcare has a net margin of 85.46% compared to International Biotechnology's net margin of 82.27%. International Biotechnology's return on equity of 27.35% beat Worldwide Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	82.27%	27.35%	3.57%
Worldwide Healthcare	85.46%	8.01%	-2.02%

6.7% of International Biotechnology shares are held by institutional investors. Comparatively, 7.9% of Worldwide Healthcare shares are held by institutional investors. 1.1% of International Biotechnology shares are held by company insiders. Comparatively, 0.2% of Worldwide Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Worldwide Healthcare has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than Worldwide Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£78.01M	4.57	£37.91M	£241.73	4.63
Worldwide Healthcare	£118.16M	11.72	£227.88M	£26.70	14.46

International Biotechnology has a beta of 0.47368002, meaning that its stock price is 53% less volatile than the broader market. Comparatively, Worldwide Healthcare has a beta of 0.262, meaning that its stock price is 74% less volatile than the broader market.

Summary

Worldwide Healthcare beats International Biotechnology on 9 of the 15 factors compared between the two stocks.

How does International Biotechnology compare to The Bankers Investment Trust?

The Bankers Investment Trust (LON:BNKR) and International Biotechnology (LON:IBT) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

0.5% of The Bankers Investment Trust shares are owned by institutional investors. Comparatively, 6.7% of International Biotechnology shares are owned by institutional investors. 0.1% of The Bankers Investment Trust shares are owned by company insiders. Comparatively, 1.1% of International Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

The Bankers Investment Trust has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than The Bankers Investment Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Bankers Investment Trust	£322.40M	4.27	£218.53M	£30.13	4.97
International Biotechnology	£78.01M	4.57	£37.91M	£241.73	4.63

The Bankers Investment Trust has a net margin of 1,132.30% compared to International Biotechnology's net margin of 82.27%. International Biotechnology's return on equity of 27.35% beat The Bankers Investment Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Bankers Investment Trust	1,132.30%	22.55%	6.13%
International Biotechnology	82.27%	27.35%	3.57%

The Bankers Investment Trust pays an annual dividend of GBX 2.77 per share and has a dividend yield of 1.8%. International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.8%. The Bankers Investment Trust pays out 9.2% of its earnings in the form of a dividend. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

The Bankers Investment Trust has a beta of 0.613, suggesting that its share price is 39% less volatile than the broader market. Comparatively, International Biotechnology has a beta of 0.47368002, suggesting that its share price is 53% less volatile than the broader market.

In the previous week, International Biotechnology had 1 more articles in the media than The Bankers Investment Trust. MarketBeat recorded 1 mentions for International Biotechnology and 0 mentions for The Bankers Investment Trust. The Bankers Investment Trust's average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score.

Company	Overall Sentiment
The Bankers Investment Trust	Neutral
International Biotechnology	Neutral

Summary

The Bankers Investment Trust and International Biotechnology tied by winning 7 of the 14 factors compared between the two stocks.

How does International Biotechnology compare to Aberforth Smaller Companies Trust?

International Biotechnology (LON:IBT) and Aberforth Smaller Companies Trust (LON:ASL) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Aberforth Smaller Companies Trust has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than Aberforth Smaller Companies Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£78.01M	4.57	£37.91M	£241.73	4.63
Aberforth Smaller Companies Trust	£94.68M	14.25	£255.01M	£115.78	15.11

In the previous week, International Biotechnology and International Biotechnology both had 1 articles in the media. Aberforth Smaller Companies Trust's average media sentiment score of 1.13 beat International Biotechnology's score of 0.00 indicating that Aberforth Smaller Companies Trust is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Biotechnology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aberforth Smaller Companies Trust	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

6.7% of International Biotechnology shares are held by institutional investors. Comparatively, 13.1% of Aberforth Smaller Companies Trust shares are held by institutional investors. 1.1% of International Biotechnology shares are held by insiders. Comparatively, 0.4% of Aberforth Smaller Companies Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

International Biotechnology has a net margin of 82.27% compared to Aberforth Smaller Companies Trust's net margin of 63.47%. International Biotechnology's return on equity of 27.35% beat Aberforth Smaller Companies Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	82.27%	27.35%	3.57%
Aberforth Smaller Companies Trust	63.47%	6.52%	11.67%

International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.8%. Aberforth Smaller Companies Trust pays an annual dividend of GBX 46.80 per share and has a dividend yield of 2.7%. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Aberforth Smaller Companies Trust pays out 40.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Biotechnology is clearly the better dividend stock, given its higher yield and lower payout ratio.

International Biotechnology has a beta of 0.47368002, meaning that its stock price is 53% less volatile than the broader market. Comparatively, Aberforth Smaller Companies Trust has a beta of 1.4412928, meaning that its stock price is 44% more volatile than the broader market.

Summary

Aberforth Smaller Companies Trust beats International Biotechnology on 8 of the 14 factors compared between the two stocks.

How does International Biotechnology compare to BH Macro GBP?

BH Macro GBP (LON:BHMG) and International Biotechnology (LON:IBT) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

BH Macro GBP has a beta of 0.1291358, meaning that its share price is 87% less volatile than the broader market. Comparatively, International Biotechnology has a beta of 0.47368002, meaning that its share price is 53% less volatile than the broader market.

1.6% of BH Macro GBP shares are owned by institutional investors. Comparatively, 6.7% of International Biotechnology shares are owned by institutional investors. 0.1% of BH Macro GBP shares are owned by insiders. Comparatively, 1.1% of International Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

International Biotechnology has a net margin of 82.27% compared to BH Macro GBP's net margin of 54.44%. International Biotechnology's return on equity of 27.35% beat BH Macro GBP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BH Macro GBP	54.44%	7.42%	-0.31%
International Biotechnology	82.27%	27.35%	3.57%

BH Macro GBP has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than BH Macro GBP, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BH Macro GBP	£277.60M	4.94	£53.77M	£45.68	9.27
International Biotechnology	£78.01M	4.57	£37.91M	£241.73	4.63

In the previous week, International Biotechnology had 1 more articles in the media than BH Macro GBP. MarketBeat recorded 1 mentions for International Biotechnology and 0 mentions for BH Macro GBP. BH Macro GBP's average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score.

Company	Overall Sentiment
BH Macro GBP	Neutral
International Biotechnology	Neutral

Summary

International Biotechnology beats BH Macro GBP on 8 of the 12 factors compared between the two stocks.

How does International Biotechnology compare to JPMorgan Emerging Markets?

JPMorgan Emerging Markets (LON:JMG) and International Biotechnology (LON:IBT) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

JPMorgan Emerging Markets pays an annual dividend of GBX 1.95 per share and has a dividend yield of 1.4%. International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.8%. JPMorgan Emerging Markets pays out 42.1% of its earnings in the form of a dividend. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Biotechnology is clearly the better dividend stock, given its higher yield and lower payout ratio.

14.8% of JPMorgan Emerging Markets shares are held by institutional investors. Comparatively, 6.7% of International Biotechnology shares are held by institutional investors. 0.0% of JPMorgan Emerging Markets shares are held by insiders. Comparatively, 1.1% of International Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

JPMorgan Emerging Markets has a net margin of 95.26% compared to International Biotechnology's net margin of 82.27%. International Biotechnology's return on equity of 27.35% beat JPMorgan Emerging Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
JPMorgan Emerging Markets	95.26%	19.61%	1.55%
International Biotechnology	82.27%	27.35%	3.57%

JPMorgan Emerging Markets has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, International Biotechnology has a beta of 0.47368002, indicating that its share price is 53% less volatile than the broader market.

JPMorgan Emerging Markets has higher earnings, but lower revenue than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than JPMorgan Emerging Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
JPMorgan Emerging Markets	£56.31M	23.64	£80.10M	£4.63	29.33
International Biotechnology	£78.01M	4.57	£37.91M	£241.73	4.63

In the previous week, JPMorgan Emerging Markets and JPMorgan Emerging Markets both had 1 articles in the media. JPMorgan Emerging Markets' average media sentiment score of 0.75 beat International Biotechnology's score of 0.00 indicating that JPMorgan Emerging Markets is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
JPMorgan Emerging Markets	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
International Biotechnology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

JPMorgan Emerging Markets and International Biotechnology tied by winning 7 of the 14 factors compared between the two stocks.

Get International Biotechnology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IBT vs. The Competition

Export

Metric	International Biotechnology	Capital Markets Industry	Finance Sector	LON Exchange
Market Cap	£356.19M	£5.67B	£14.01B	£2.90B
Dividend Yield	2.76%	7.36%	5.88%	6.17%
P/E Ratio	4.63	31.62	26.07	367.25
Price / Sales	4.57	1,205.99	512.53	83,668.65
Price / Cash	155.74	48.16	38.46	27.89
Price / Book	1.46	1.96	2.09	6.92
Net Income	£37.91M	£418.14M	£1.32B	£5.89B
7 Day Performance	-1.32%	-0.73%	-0.86%	-0.35%
1 Month Performance	9.80%	1.75%	1.84%	2.81%
1 Year Performance	62.32%	7.09%	11.29%	23.12%

International Biotechnology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IBT International Biotechnology	N/A	GBX 1,120 -1.3%	N/A	+65.7%	£356.19M	£78.01M	4.63	N/A
WWH Worldwide Healthcare	N/A	GBX 391.50 -0.4%	N/A	+16.1%	£1.40B	£118.16M	14.66	N/A	Positive News
BNKR The Bankers Investment Trust	N/A	GBX 151.60 +0.4%	N/A	+21.2%	£1.39B	£322.40M	5.03	N/A
ASL Aberforth Smaller Companies Trust	N/A	GBX 1,780 +0.2%	N/A	+13.9%	£1.37B	£94.68M	15.37	N/A	Positive News
BHMG BH Macro GBP	N/A	GBX 424 -0.1%	N/A	+8.5%	£1.35B	£277.60M	9.28	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IBT) was last updated on 9/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

International Biotechnology (IBT) Competitors

IBT vs. WWH, BNKR, ASL, BHMG, and JMG

How does International Biotechnology compare to Worldwide Healthcare?

Summary

How does International Biotechnology compare to The Bankers Investment Trust?

Summary

How does International Biotechnology compare to Aberforth Smaller Companies Trust?

Summary

How does International Biotechnology compare to BH Macro GBP?

Summary

How does International Biotechnology compare to JPMorgan Emerging Markets?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBT vs. The Competition

International Biotechnology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

International Biotechnology (IBT) Competitors

IBT vs. WWH, BNKR, ASL, BHMG, and JMG

How does International Biotechnology compare to Worldwide Healthcare?

Does the media prefer IBT or WWH?

Is IBT or WWH a better dividend stock?

Is IBT or WWH more profitable?

Do insiders & institutionals hold more shares of IBT or WWH?

Which has preferable earnings & valuation, IBT or WWH?

Which has more volatility and risk, IBT or WWH?

Summary

How does International Biotechnology compare to The Bankers Investment Trust?

Do institutionals and insiders hold more shares of BNKR or IBT?

Which has stronger valuation & earnings, BNKR or IBT?

Is BNKR or IBT more profitable?

Is BNKR or IBT a better dividend stock?

Which has more volatility & risk, BNKR or IBT?

Does the media refer more to BNKR or IBT?

Summary

How does International Biotechnology compare to Aberforth Smaller Companies Trust?

Which has preferable valuation & earnings, IBT or ASL?

Does the media favor IBT or ASL?

Do insiders & institutionals hold more shares of IBT or ASL?

Is IBT or ASL more profitable?

Is IBT or ASL a better dividend stock?

Which has more volatility & risk, IBT or ASL?

Summary

How does International Biotechnology compare to BH Macro GBP?

Which has more risk and volatility, BHMG or IBT?

Do institutionals and insiders hold more shares of BHMG or IBT?

Is BHMG or IBT more profitable?

Which has stronger earnings & valuation, BHMG or IBT?

Does the media prefer BHMG or IBT?

Summary

How does International Biotechnology compare to JPMorgan Emerging Markets?

Is JMG or IBT a better dividend stock?

Do institutionals & insiders have more ownership in JMG or IBT?

Is JMG or IBT more profitable?

Which has more risk & volatility, JMG or IBT?

Which has higher earnings & valuation, JMG or IBT?

Does the media refer more to JMG or IBT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBT vs. The Competition

International Biotechnology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools